GPX4 and adenocarcinoma: This finding also supports our present study: Figure 6D,E reveal that GPX4, xCT, and NRF2 expression was downregulated whereas HO-1, LSH, and KEAP1 expression was upregulated by co-treatment in both adenocarcinoma cell lines.